Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Technology Week Liechtenstein.
Liechtenstein Bankers Association CEO Featured in CEO Insight: Driving Sustainable Finance and Innovation
EIN Presswire
·
July 7, 2025
How the LBA is balancing tradition, transparency, and technology to shape the future of Liechtenstein’s financial centre LONDON, UNITED KINGDOM, July 7, 2025 /EINPresswire.com/ -- Simon Tribelhorn, CEO of the Liechtenstein Bankers Association...
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
GlobeNewswire, Inc.
·
April 28, 2025
VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a healthcare professional PITTSBURGH, April 28,...
4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion
GlobeNewswire, Inc.
·
March 17, 2025
Press Release 4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion Araris will receive USD 400 million upfront, with the potential for additional near-term and long-term milestone payments...
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
GlobeNewswire, Inc.
·
February 28, 2025
PITTSBURGH, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's (EMA’s) announcement that its Committee for Medicinal...
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
GlobeNewswire, Inc.
·
March 3, 2025
BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio (a...
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
GlobeNewswire, Inc.
·
March 3, 2025
BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio...
New Business Development through the Expansion of Swiss Security Solutions LLC's - Securely Swiss® Online Shopify Store
EIN Presswire
·
August 13, 2025
The first Swiss Security & Investigations Trademark Securely Swiss® is now on Shopify, selling a part of their security and intelligence services and solutions. ZURICH, ZURICH ZH, SWITZERLAND, August 13, 2025 /EINPresswire.com/ -- The first...
Crypto Exchange LCX Files Pre-Application For MiCA License in Liechtenstein
GlobeNewswire, Inc.
·
December 24, 2024
Vaduz, Liechtenstein, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LCX, the Liechtenstein Cryptoassets Exchange, has officially filed a pre-application for the Pan-European MiCA (Markets in Crypto Assets Regulation) license under Liechtenstein’s Financial...
ISC’s Technology Solutions Segment Wins Liechtenstein Contract to Deliver a Digital Commercial Registry System
GlobeNewswire, Inc.
·
November 28, 2024
ISC wins contract with the Principality of Liechtenstein. Total contract valued at CHF$6.2 million (CA$10.0 million) over 5 years. Along with implementation, support and maintenance are included. Demonstrates ISC’s continued growth and expansion...
Increasing Oral Healthcare Awareness to Propel Dental Equipment Market Growth at USD 10.90 Billion by 2031 |SkyQuest Technology
GlobeNewswire, Inc.
·
October 18, 2024
Westford, USA, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Dental Equipment Market size was valued at USD 6.79 billion in 2023 to USD 10.90 billion by 2031, growing at a CAGR of 6.10% during the forecast period (2024-2031). The tools that are utilized for...
Dental Consumables Market to Reach USD 53.27 Billion by 2031, Growing at 7.8% CAGR | SkyQuest Technology
GlobeNewswire, Inc.
·
September 18, 2024
Westford, USA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Dental Consumables Market will attain the value of USD 53.27 Billion by 2031, with a CAGR of 7.8% during the forecast period (2024-2031). Increased incidence of dental...
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
GlobeNewswire, Inc.
·
September 4, 2024
PALM BEACH, Fla., Sept. 04, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The SARS-CoV-2, literally affected the whole world in these past years and has increased a global search for therapies and treatments. A report from Transparency...
Obyte City initial sale completes, generous referral rewards begin
EIN Presswire
·
July 4, 2025
Obyte City initial sale has completed. Now plots in the Obyte City are sold only for CITY, and referrers can earn 10% of what their referrals spend. VADUZ, LIECHTENSTEIN, July 4, 2025 /EINPresswire.com/ -- The first chapter of Obyte City has...
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
GlobeNewswire, Inc.
·
June 20, 2025
VYVGART® SC, first-and-only IgG Fc-antibody fragment which specifically targets the neonatal Fc receptor (FcRn), now approved for use in Europe for CIDP Approval based on ADHERE clinical trial, the largest study of CIDP patients to date First...
Dental Implants Market worth US$18.79 billion by 2030 with 8.4% CAGR | MarketsandMarkets™.
GlobeNewswire, Inc.
·
June 19, 2025
Delray Beach, FL, June 19, 2025 (GLOBE NEWSWIRE) -- The global dental implants market, valued at US$11.61 billion in 2024, stood at US$12.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in...
Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
GlobeNewswire, Inc.
·
July 28, 2025
CELEBRATION, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare diseases, announced the company submitted...
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
GlobeNewswire, Inc.
·
July 21, 2025
Approval is based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicity EC approval follows positive CHMP opinion, MHRA conditional marketing...
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire, Inc.
·
June 6, 2025
Now approved in the EU, Duvyzat offers an important treatment option for delaying Duchenne muscular dystrophy (DMD) disease progression Duvyzat is an orally administered treatment for DMD in patients 6 years and older who are able to walk The...
The European Magazine Releases Its Summer 2025 Edition
EIN Presswire
·
July 22, 2025
From financial reform and investment migration to AI, climate resilience and cultural diplomacy, uncover the real forces shaping Europe’s global influence. LONDON, UNITED KINGDOM, July 22, 2025 /EINPresswire.com/ -- With a high-stakes EU–China...
Introducing Obyte City: A Community Space to Find Neighbors and Earn Rewards
EIN Presswire
·
June 3, 2025
Obyte City is a new community space for Obyte to strengthen connections between community members TRIESEN, LIECHTENSTEIN, June 3, 2025 /EINPresswire.com/ -- Obyte proudly unveils Obyte City, a cypherpunk-inspired digital space designed to...